会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Method for accurately enumerating and sensitively qualifying
heterogenous cell populations in cytolytic processing conditions
    • 在细胞溶解处理条件下准确地枚举和敏感鉴定异源细胞群体的方法
    • US5378633A
    • 1995-01-03
    • US197575
    • 1994-02-16
    • Wieland E. von BehrensSherry HaiflichJohn GlazierJohn M. RocheBruce A. Director
    • Wieland E. von BehrensSherry HaiflichJohn GlazierJohn M. RocheBruce A. Director
    • G01N33/49C12M1/34G01N15/14G01N33/50G01N33/48
    • G01N33/5094G01N15/1434G01N15/1459G01N2015/1006G01N2015/1402G01N2015/1413G01N2015/1477Y10T436/107497
    • A method for identifying, characterizing, categorizing and enumerating cells within a cell population. The survivorship characteristics of the different cell populations is used to obtain quantitative and qualitative information about the cell populations initially present in the sample solution before conditions were imposed on the sample solution to elicit a response. The monitored cell survivorship response may be either direct disappearance of intact cells or the appearance of cell structures, carcasses, ghosts or residuum. In a preferred embodiment, a leukocyte cell decay rate in the presence of an erythrolytic agent is determined by monitoring leukocyte counts at several time intervals after the addition of the erythrolytic agent to the sample solution. The leukocyte decay rate is then used to indicate the presence of a fragile leukocyte population, and to accurately estimate the number of leukocytes initially present in the whole blood sample. The use of stronger erythrolytic agents in samples with lyse-resistant erythrocytes while preserving the accuracy of leukocyte counts is allowed. The present method permits calculation of a leukocyte decay rate which can be back extrapolated to time zero to provide an accurate estimate of the leukocyte count initially present in the whole blood sample.
    • 用于识别,表征,分类和枚举细胞群体中的细胞的方法。 不同细胞群体的存活特征用于获得关于样品溶液中最初存在的细胞群的定量和定性信息,然后再对样品溶液施加条件以引发反应。 受监测的细胞存活应答可能是完整细胞的直接消失或细胞结构,胴体,幽灵或残渣的出现。 在优选的实施方案中,在将红细胞溶解剂加入到样品溶液中之后,通过在几个时间间隔监测白细胞计数来确定在存在红血球分解剂的情况下的白血球细胞衰变速率。 然后使用白细胞衰减速率来指示脆性白细胞群的存在,并准确估计最初存在于全血样品中的白细胞数。 允许在具有抗裂红细胞的样品中使用更强的红血球,同时保持白细胞计数的准确性。 本方法允许计算白细胞衰减速率,其可以反向外推到时间零,以提供最初存在于全血样品中的白细胞计数的准确估计。
    • 3. 发明授权
    • Particulate matter analyzing apparatus and method
    • 颗粒物分析装置及方法
    • US4710021A
    • 1987-12-01
    • US837875
    • 1986-03-05
    • Wieland E. von Behrens
    • Wieland E. von Behrens
    • G01N15/12G01N15/14G01N21/85
    • G01N15/1245
    • A method and apparatus for jetting a measured volume of a suspension of particulates such as blood cells or colloids into a single fluid-primed incompletely partitioned transducer chamber in such a way that the dynamic relationship between the priming liquid and the inflowing jet imparts to the suspended particulates the properties of a stable stream line monofile which reliably traverses one or more particulate-identifying and/or analyzing sensing zones. Said transducer chamber has one or more of the following three sources of energy for moving the contained fluids: an easily maintained non-critical pressure differential between the suspension inflow port and an exit line, potential energy stored within the transducer chamber during the priming step, a pump mechanism to propel particulate-free fluid. The measurement period in all such transducers may be defined by monitoring the volume of either the inflowing or displaced outflowing liquid.
    • 将测量体积的诸如血细胞或胶体的颗粒悬浮液喷射到单个流体填充的不完全分隔的换能器室中的方法和装置,使得起动液体和流入喷射器之间的动态关系赋予悬浮液 颗粒化可靠地穿过一个或多个颗粒识别和/或分析感测区域的稳定流线单体的性质。 所述传感器腔室具有用于移动所容纳流体的以下三种能量源中的一种或多种:在悬浮液流入口和出口管线之间容易维持的非临界压力差,在启动步骤期间存储在换能器室内的势能, 泵机构,用于推进无颗粒流体。 所有这些换能器中的测量周期可以通过监测流入或流出的流出液体的体积来定义。